Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Gains from Investment Securities (2016 - 2025)

IGC Pharma has reported Gains from Investment Securities over the past 16 years, most recently at $11000.0 for Q1 2025.

  • Quarterly Gains from Investment Securities rose 105.61% to $11000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$171000.0 through Mar 2025, up 27.23% year-over-year, with the annual reading at $25000.0 for FY2025, 116.23% up from the prior year.
  • Gains from Investment Securities was $11000.0 for Q1 2025 at IGC Pharma, down from $14000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $66000.0 in Q1 2023 and troughed at -$2.0 million in Q1 2021.
  • The 5-year median for Gains from Investment Securities is -$47000.0 (2022), against an average of -$291875.0.
  • Year-over-year, Gains from Investment Securities crashed 488.89% in 2022 and then skyrocketed 143.42% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $27000.0 in 2021, then crashed by 488.89% to -$105000.0 in 2022, then skyrocketed by 162.86% to $66000.0 in 2023, then tumbled by 78.79% to $14000.0 in 2024, then decreased by 21.43% to $11000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Gains from Investment Securities are $11000.0 (Q1 2025), $14000.0 (Q4 2024), and -$196000.0 (Q1 2024).